- In February 2023, Philips introduced a multiparametric MRI and MRI/ultrasound fusion approach for prostate cancer diagnosis. This technique improves diagnostic accuracy by using MRI to identify suspicious lesions in the prostate, helping urologists to better target biopsies. The fusion of MRI and ultrasound images allows for real-time, precise targeting of high-risk cancerous areas, offering an alternative to traditional biopsies. The technology enhances the ability to detect clinically significant prostate cancer early, providing a more confident diagnosis and faster initiation of treatment. This advancement aims to improve patient outcomes, particularly for those with prior negative biopsies
